Holen Sie sich die Stockscreener-App
14.62
0.10%
-0.015
Handel nachbörslich:
14.62
Schlusskurs vom Vortag:
$14.63
Offen:
$14.63
24-Stunden-Volumen:
1.32M
Relative Volume:
1.72
Marktkapitalisierung:
$1.54B
Einnahmen:
-
Nettoeinkommen (Verlust:
$-150.70M
KGV:
-9.4323
EPS:
-1.55
Netto-Cashflow:
$-125.67M
1W Leistung:
-0.20%
1M Leistung:
+7.42%
6M Leistung:
-40.33%
1J Leistung:
-18.46%
1-Tages-Spanne:
$14.30
$14.72
1-Wochen-Bereich:
$14.12
$15.12
52-Wochen-Spanne:
$10.60
$38.12
Edgewise Therapeutics Inc Stock (EWTX) Company Profile
Firmenname
Edgewise Therapeutics Inc
Sektor
Branche
Telefon
720-262-7002
Adresse
1715 38TH ST, BOULDER
Vergleichen Sie EWTX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
EWTX
Edgewise Therapeutics Inc
|
14.62 | 1.57B | 0 | -150.70M | -125.67M | -1.55 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.93 | 102.81B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
453.54 | 58.59B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
567.22 | 61.25B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
733.66 | 43.23B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
318.73 | 36.53B | 3.81B | -644.79M | -669.77M | -6.24 |
Edgewise Therapeutics Inc Stock (EWTX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-07-30 | Eingeleitet | Raymond James | Strong Buy |
| 2025-06-30 | Eingeleitet | H.C. Wainwright | Buy |
| 2025-04-30 | Eingeleitet | Guggenheim | Buy |
| 2025-04-02 | Herabstufung | Scotiabank | Sector Outperform → Sector Perform |
| 2025-03-07 | Eingeleitet | Scotiabank | Sector Outperform |
| 2025-01-22 | Eingeleitet | Stifel | Hold |
| 2024-11-22 | Eingeleitet | Evercore ISI | Outperform |
| 2024-03-07 | Eingeleitet | Piper Sandler | Overweight |
| 2023-05-01 | Eingeleitet | Truist | Buy |
| 2022-08-25 | Herabstufung | Goldman | Neutral → Sell |
| 2022-04-13 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2022-01-28 | Eingeleitet | Goldman | Neutral |
Alle ansehen
Edgewise Therapeutics Inc Aktie (EWTX) Neueste Nachrichten
Edgewise Therapeutics' Strategic Use of Inducement Grants to Fuel Long-Term Growth in a High-Potential Biopharma Sector - AInvest
Siren L.L.C. Raises Stake in Edgewise Therapeutics, Inc. $EWTX - MarketBeat
Will Edgewise Therapeutics Inc. outperform tech stocksTrade Performance Summary & High Conviction Buy Zone Picks - khodrobank.com
16,500 Stock Options at $14.35: Edgewise Therapeutics Awards Inducement Grants to New Hires - Stock Titan
Edgewise Therapeutics Inc. stock daily chart insights2025 Year in Review & Risk Managed Investment Entry Signals - Newser
Signal strength of Edgewise Therapeutics Inc. stock in tech scannersWeekly Gains Summary & Risk Adjusted Swing Trade Ideas - Newser
Braidwell LP Has $54.09 Million Position in Edgewise Therapeutics, Inc. $EWTX - MarketBeat
What’s the recovery path for long term holders of Edgewise Therapeutics Inc.July 2025 Weekly Recap & Fast Entry High Yield Stock Tips - Newser
Should you hold or exit Edgewise Therapeutics Inc. now2025 Top Decliners & Community Consensus Trade Signals - Newser
What moving averages say about Edgewise Therapeutics Inc.2025 Fundamental Recap & Accurate Entry/Exit Alerts - Newser
Will Edgewise Therapeutics Inc. outperform the market2025 Fundamental Recap & AI Driven Stock Reports - Newser
Published on: 2025-09-03 03:49:28 - Newser
Understanding Edgewise Therapeutics Inc.’s price movementJuly 2025 EndofMonth & Fast Entry High Yield Stock Tips - Newser
Using Ichimoku Cloud for Edgewise Therapeutics Inc. technicalsJuly 2025 Final Week & Risk Managed Investment Signals - Newser
Is it time to cut losses on Edgewise Therapeutics Inc.Options Play & Weekly Return Optimization Plans - Newser
Will Edgewise Therapeutics Inc. stock go up soonGlobal Markets & High Return Stock Watch Alerts - Newser
Should you avoid Edgewise Therapeutics Inc. stock right nowQuarterly Market Review & AI Driven Stock Movement Reports - khodrobank.com
Using data tools to time your Edgewise Therapeutics Inc. exit2025 AllTime Highs & Smart Allocation Stock Tips - Newser
What earnings revisions data tells us about Edgewise Therapeutics Inc.July 2025 Gainers & Stepwise Trade Signal Implementation - Newser
What is the target price for Edgewise Therapeutics Inc. stockJuly 2025 Technicals & Reliable Entry Point Alerts - khodrobank.com
Wall Street Analysts Believe Edgewise Therapeutics (EWTX) Could Rally 172.96%: Here's is How to Trade - sharewise.com
What is Edgewise Therapeutics Inc.’s book value per shareJuly 2025 Spike Watch & Smart Allocation Stock Reports - khodrobank.com
How to manage a losing position in Edgewise Therapeutics Inc.Weekly Loss Report & Accurate Technical Buy Alerts - Newser
Edgewise Therapeutics, Inc. $EWTX Shares Sold by Wellington Management Group LLP - MarketBeat
Volume spikes in Edgewise Therapeutics Inc. stock – what they meanTrade Volume Summary & Weekly Stock Breakout Alerts - Newser
Sentiment analysis tools applied to Edgewise Therapeutics Inc.2025 Market WrapUp & Fast Momentum Stock Entry Tips - Newser
Nuveen LLC Invests $4.46 Million in Edgewise Therapeutics, Inc. $EWTX - MarketBeat
Can Edgewise Therapeutics Inc. expand into new marketsMarket Activity Summary & AI Forecasted Entry and Exit Points - khodrobank.com
Is Edgewise Therapeutics Inc. stock poised for growthProduct Launch & Reliable Price Action Trade Plans - Newser
Is Edgewise Therapeutics Inc. a strong growth stockGlobal Markets & Consistent Income Trade Recommendations - khodrobank.com
Can Edgewise Therapeutics Inc. ride the EV wave2025 Major Catalysts & Intraday High Probability Setup Alerts - khodrobank.com
Published on: 2025-09-01 15:40:50 - Newser
Using economic indicators to assess Edgewise Therapeutics Inc. potentialGold Moves & Safe Capital Investment Plans - Newser
Support Zone Holds Steady for Edgewise Therapeutics Inc. After Dip getLinesFromResByArray error: size == 0 - kangso.co.kr
Edgewise Therapeutics Inc. Facing Inflection Point in Trend Analysis getLinesFromResByArray error: size == 0 - thegnnews.com
Edgewise Therapeutics, Inc. $EWTX Stock Position Reduced by Driehaus Capital Management LLC - MarketBeat
How Edgewise Therapeutics Inc. stock performs during market volatilityMarket Performance Report & Expert Approved Momentum Trade Ideas - Newser
Analyzing drawdowns of Edgewise Therapeutics Inc. with statistical toolsWeekly Trade Report & Verified Stock Trade Ideas - Newser
Key resistance and support levels for Edgewise Therapeutics Inc.Price Action & Precise Entry and Exit Recommendations - Newser
Regression analysis insights on Edgewise Therapeutics Inc. performancePortfolio Risk Report & Smart Swing Trading Alerts - Newser
Finanzdaten der Edgewise Therapeutics Inc-Aktie (EWTX)
Umsatz
Nettogewinn
Free Cashflow
ENV
Edgewise Therapeutics Inc-Aktie (EWTX) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Russell Alan J | Chief Scientific Officer |
Aug 26 '25 |
Sale |
14.60 |
100,000 |
1,459,760 |
23,400 |
1.75%
1.11%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):